Opinion: Tested in Africa, used in America
At the recent annual International AIDS Conference, a startling presentation about the newest wonder drug…
Category: clinical trials
STAT+: AstraZeneca’s Imfinzi increases survival rates in bladder cancer in pivotal study
BARCELONA, Spain — An AstraZeneca immunotherapy, given both before and after surgery, improved survival rates…
STAT+: Former Verily executives hatch plan to invest millions in high-tech medical data
Two former Verily executives say that they are starting a new initiative, Highlander Health, to…
Q&A: Atsena Therapeutics’ gene therapy for inherited blindness shows promise
Seven years after the FDA approved Luxterna, scientists have yet to bring another congenital blindness…
STAT+: Recursion presents mixed data on lead AI-derived drug candidate for potentially fatal brain condition
Recursion Pharmaceuticals announced results of a clinical trial for its lead drug candidate Tuesday that,…
STAT+: Sanofi says its new pill for multiple sclerosis succeeded in a key trial, boosting its research ambitions
Sanofi said an oral treatment for multiple sclerosis, tolebrutinib, met its key goal in a…
Glucose monitors, mpox vaccine inequity and effects of LGBTQ+ restrictions
STAT’s coverage of chronic health issues is supported by a grant from Bloomberg Philanthropies. Our financial…
Opinion: The importance of reducing the financial burden of participating in clinical trials
Scientific advancements have helped millions of people living with cancer, heart disease, arthritis, obesity, and…
Alzheimer’s drug may raise the risk of brain bleed in patients with Down syndrome
A year ago, after much fanfare and controversy, the Food and Drug Administration approved Eisai…
STAT+: Congressional probe questions clinical trials run in China, citing Army involvement
A House committee is investigating whether brand drug companies are collaborating with the Chinese military…
Clinical trials exclude disabled Americans because federal agencies failed them, new report finds
People with disabilities are largely excluded from clinical trials that could benefit them because federal…
STAT+: Acelyrin announces layoffs, strategy shift after late-stage trial results for anti-inflammatory drug
Acelyrin, a California biotech focused on immunology and inflammatory disease, announced Tuesday that its experimental…
STAT+: ‘Jerking families around’: Canceled Roche rare disease trial devastates parents, angers researchers
Roche, the Swiss pharmaceutical giant, earlier this year abruptly cancelled an international clinical trial of…
Opinion: Expand community-based research to make clinical trials more diverse
Innovations in clinical trial designs and tools have the potential to unlock a new era…
Opinion: What readers have to say about long Covid, FDA and diversity, and more
First Opinion is STAT’s platform for interesting, illuminating, and maybe even provocative articles about the…
FDA issues long-awaited draft guidance for enrolling more people of color in clinical trials
The Food and Drug Administration has drafted guidance aimed at getting drug companies and medical…
STAT+: Vertex reports positive results in stem cell trial for type 1 diabetes
ORLANDO — Twelve people with type 1 diabetes who received a therapy derived from stem…
STAT+: New immunotherapy combination could ‘change the landscape’ of cancer treatment
When they work, immunotherapy drugs called checkpoint inhibitors can shrink cancers and, in some cases,…
STAT+: Gilead’s twice-yearly antiviral protected women from HIV infection in large trial
Gilead said Thursday that twice-a-year injections of a new antiviral drug, called lenacapavir, completely protected…
Walgreens executive says it is ‘doubling down’ on recruiting customers into clinical trials
LOS ANGELES – For the past two years, Walgreens has tried to leverage its nationwide…
NIH wanted to make cancer research more diverse. The effort turned out to be a costly failure
Government researchers hoped to attract a more diverse group of patients for clinical research by…
STAT+: Medical device trials still don’t enroll enough women, study finds
Women have always been underrepresented in medical research. A new study reveals that not much…
NIH will bring clinical research into primary care offices with $30 million pilot
For many Americans, health care means going to a local primary care office. But the…
STAT+: ASCO Daily Recap: A CAR-T advance, money talk, and tossing the cancer treatment ‘sandwich’
You’re reading the web edition of ASCO in 30 Seconds, STAT’s guide to the American…
Listen: An ASCO preview & another Duchenne trial failure
Which presentations are worth catching at ASCO this weekend? What is exon-skipping? And how do…
STAT+: Duchenne muscular dystrophy drug from Nippon Shinyaku fails in rare confirmatory trial
Japanese drugmaker Nippon Shinyaku said on Monday that its Duchenne muscular dystrophy drug, Viltepso, part…
Opinion: STAT+: Unmasking the ‘centricity’ illusion in clinical trials
During my 25 years working in clinical trial operations, I’ve seen the biopharmaceutical world talk…
STAT+: Pharma’s losing bet in New Jersey
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and…
Opinion: Making the case for fair compensation in clinical trials
I’ve been on three sides of the health care equation: I’ve beaten stage 4 colorectal…
STAT+: Wearable devices generate powerful data but it’s not useful to doctors, yet
Just because the Food and Drug Administration has given the Apple Watch and other wearable…
STAT+: Novo to test Wegovy and other obesity drugs against alcohol-related liver disease
Novo Nordisk will test whether its GLP-1 drugs can help people with alcohol-associated liver disease,…
STAT+: Health care leaders plot how to expand diversity in clinical trials
Even with the recent awareness that clinical trials often lack the diversity that would make…
Cell therapy fails to slow early type 1 diabetes, but safety is established
Tolerance is the holy grail in calming autoimmune disease, a truce in the immune system’s…
STAT+: Gene therapy trial targeting rare form of deafness shows ‘jaw-droppingly good’ results
Two congenitally deaf children can hear for the first time after being treated with gene…
STAT+: Apple pushes into clinical trials with new FDA nod for Apple Watch
The Apple Watch has secured a new qualification from the Food and Drug Administration that…
STAT+: House bill aimed at Chinese biotechs is advancing
Want to stay on top of the science and politics driving biotech today? Sign up to get…
STAT+: Doctors Without Borders challenges pharma by releasing costs for a key clinical trial
In a challenge to the pharmaceutical industry, Doctors Without Borders has revealed the detailed costs…
STAT+: Animal rights group urges SEC to investigate Charles River over monkey purchases
A leading animal rights group has asked securities regulators to investigate Charles River Laboratories for…
Parkinson’s disease may be helped by GLP-1 drug, new study finds
The booming class of GLP-1 drugs that includes Ozempic and Wegovy is not only effective…
STAT+: U.K. becomes the first country to release detailed data on sponsors that fail to register clinical trials
The United Kingdom has released comprehensive data showing which institutions have failed to register their…
STAT+: Amylyx ALS drug failure leaves patients, advocates, and researchers reeling — and wondering what’s next
The latest disappointment in amyotrophic lateral sclerosis research brought crushing news for patients and physicians,…
STAT+: Icon acquires HumanFirst to boost support for digital tools in clinical trials
As pharma companies wrestle with how and when to use wearables and other digital technologies…
STAT+: FDA gives a mixed response to a petition seeking greater clinical trial transparency
The U.S. Food and Drug Administration told an advocacy group that it is not planning…
STAT+: Biotech launches with $135 million for Vertex-competing pain medicine
After three years being incubated by California VC Westlake Village BioPartners, a new biotech launched…
STAT+: Lasers, cardiology, clinical trials: 2023’s top private equity targets
By some measures, private equity investment lagged in 2023, a year marked by growing distress…
STAT+: Survey: Confusion over key requirements means clinical trials aren’t registered and results aren’t reported
More than half of those responsible for registering clinical trials and reporting results fail to…
STAT+: Bayer’s promising menopause drug trial results highlight growing interest in long-neglected condition
More hopeful news on the menopause front: Bayer announced on Monday encouraging results in two…
STAT+: Insitro, biotech AI’s quiet unicorn, unveils efforts in ALS, liver disease, and cancer at JPM
New artificial intelligence technologies made headlines last year for their ability to do everything from…
STAT+: An injectable gel enters the male birth control fray with early positive clinical data
Between condoms and vasectomies lies a vast, undeveloped chasm of male birth control. Contraline, a…
Opinion: Does food as medicine help patients with diabetes? Here’s what a new clinical trial says
Food-as-medicine programs that address food insecurity and diet-related chronic diseases have drawn widespread attention from…